| Adverse drug reaction reporting by patients in the Netherlands three years of experience J de Langen, F van Hunsel, A Passier, LJ den Berg, K van Grootheest Drug Safety 31, 515-524, 2008 | 244 | 2008 |
| Experiences with adverse drug reaction reporting by patients: an 11-country survey F van Hunsel, L Härmark, S Pal, S Olsson, K van Grootheest Drug safety 35, 45-60, 2012 | 187 | 2012 |
| Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an … F Van Hunsel, A Passier, K Van Grootheest British journal of clinical pharmacology 67 (5), 558-564, 2009 | 121 | 2009 |
| Motives for reporting adverse drug reactions by patient-reporters in the Netherlands F van Hunsel, C van der Welle, A Passier, E van Puijenbroek, ... European journal of clinical pharmacology 66, 1143-1150, 2010 | 96 | 2010 |
| Acute effects of nicotine on attention and response inhibition EM Bekker, KBE Böcker, F Van Hunsel, MC Van Den Berg, JL Kenemans Pharmacology Biochemistry and Behavior 82 (3), 539-548, 2005 | 90 | 2005 |
| Adverse drug reactions of montelukast in children and adults MG Haarman, F van Hunsel, TW de Vries Pharmacology research & perspectives 5 (5), e00341, 2017 | 87 | 2017 |
| ADR reporting by the general public: lessons learnt from the Dutch and Swedish systems L Härmark, F Van Hunsel, B Grundmark Drug safety 38 (4), 337-347, 2015 | 87 | 2015 |
| Adverse drug reaction reports of patients and healthcare professionals—differences in reported information L Rolfes, F van Hunsel, S Wilkes, K van Grootheest, E van Puijenbroek Pharmacoepidemiology and drug safety 24 (2), 152-158, 2015 | 76 | 2015 |
| The quality of clinical information in adverse drug reaction reports by patients and healthcare professionals: a retrospective comparative analysis L Rolfes, F van Hunsel, L van der Linden, K Taxis, E van Puijenbroek Drug safety 40, 607-614, 2017 | 70 | 2017 |
| Adverse food–drug interactions A de Boer, F Van Hunsel, A Bast Regulatory Toxicology and Pharmacology 73 (3), 859-865, 2015 | 70 | 2015 |
| The impact of experiencing adverse drug reactions on the patient’s quality of life: a retrospective cross-sectional study in the Netherlands L Rolfes, F van Hunsel, K Taxis, E van Puijenbroek Drug safety 39, 769-776, 2016 | 66 | 2016 |
| The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case–control study F van Hunsel, A Talsma, E van Puijenbroek, L de Jong‐van den Berg, ... pharmacoepidemiology and drug safety 20 (3), 286-291, 2011 | 60 | 2011 |
| Are consumers ready to take part in the Pharmacovigilance System?—A Portuguese preliminary study concerning ADR reporting C Matos, F van Hunsel, J Joaquim European journal of clinical pharmacology 71, 883-890, 2015 | 51 | 2015 |
| Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources L Davidson, JMPA van den Reek, M Bruno, F van Hunsel, RMC Herings, ... The Lancet Regional Health–Europe 13, 2022 | 50 | 2022 |
| Safety concerns reported by patients identified in a collaborative signal detection workshop using VigiBase: results and reflections from Lareb and Uppsala Monitoring Centre S Watson, RE Chandler, H Taavola, L Härmark, B Grundmark, A Zekarias, ... Drug safety 41, 203-212, 2018 | 46 | 2018 |
| Patient reporting of adverse drug reactions: an international survey of national competent authorities’ views and needs C Matos, L Härmark, F van Hunsel Drug safety 39, 1105-1116, 2016 | 44 | 2016 |
| Description of frequencies of reported adverse events following immunization among four different COVID-19 vaccine brands A Kant, J Jansen, L van Balveren, F van Hunsel Drug safety 45 (4), 319-331, 2022 | 43 | 2022 |
| The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015 F van Hunsel, S De Waal, L Härmark Pharmacoepidemiology and Drug Safety 26 (8), 977-983, 2017 | 42 | 2017 |
| Important information regarding reporting of adverse drug reactions: a qualitative study L Rolfes, S Wilkes, F van Hunsel, E van Puijenbroek, K van Grootheest International Journal of Pharmacy Practice 22 (3), 231-233, 2014 | 36 | 2014 |
| Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases F van Hunsel, S van de Koppel, E van Puijenbroek, A Kant Drug safety 41, 859-869, 2018 | 32 | 2018 |
E van PuijenbroekHoogleraar geneesmiddelenbewaking en geneesmiddelenveiligheidVerified email at home.nl
